JP2006510363A5 - - Google Patents

Download PDF

Info

Publication number
JP2006510363A5
JP2006510363A5 JP2004560521A JP2004560521A JP2006510363A5 JP 2006510363 A5 JP2006510363 A5 JP 2006510363A5 JP 2004560521 A JP2004560521 A JP 2004560521A JP 2004560521 A JP2004560521 A JP 2004560521A JP 2006510363 A5 JP2006510363 A5 JP 2006510363A5
Authority
JP
Japan
Prior art keywords
cancer
dnase
polypeptide
detection
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004560521A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006510363A (ja
JP4527544B2 (ja
Filing date
Publication date
Priority claimed from EP02102814A external-priority patent/EP1431762B1/en
Application filed filed Critical
Publication of JP2006510363A publication Critical patent/JP2006510363A/ja
Publication of JP2006510363A5 publication Critical patent/JP2006510363A5/ja
Application granted granted Critical
Publication of JP4527544B2 publication Critical patent/JP4527544B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004560521A 2002-12-18 2003-12-16 癌およびその前駆病変の検出のための化合物および方法 Expired - Lifetime JP4527544B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02102814A EP1431762B1 (en) 2002-12-18 2002-12-18 Compounds and methods for detection of carcinomas and their precursor lesions
PCT/EP2003/051028 WO2004055514A1 (en) 2002-12-18 2003-12-16 Compounds and methods for detection of carcinomas and their precursor lesions

Publications (3)

Publication Number Publication Date
JP2006510363A JP2006510363A (ja) 2006-03-30
JP2006510363A5 true JP2006510363A5 (https=) 2006-10-19
JP4527544B2 JP4527544B2 (ja) 2010-08-18

Family

ID=32338157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004560521A Expired - Lifetime JP4527544B2 (ja) 2002-12-18 2003-12-16 癌およびその前駆病変の検出のための化合物および方法

Country Status (10)

Country Link
US (2) US20060121485A1 (https=)
EP (1) EP1431762B1 (https=)
JP (1) JP4527544B2 (https=)
CN (1) CN1726393B (https=)
AT (1) ATE360817T1 (https=)
AU (1) AU2003302964A1 (https=)
CA (1) CA2510150C (https=)
DE (1) DE60219809T2 (https=)
ES (1) ES2286201T3 (https=)
WO (1) WO2004055514A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60219809T2 (de) * 2002-12-18 2008-01-17 Coy, Johannes F., Dr. Verbindungen und Verfahren zur Nachweiss von Karzinomen und deren Vorstufen
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US9248166B2 (en) * 2003-07-14 2016-02-02 Cls Therapeutics Limited Method for treating oncological diseases
EP2416156B1 (en) 2006-10-18 2015-12-30 Periness Ltd. Method for determining a male fertility status
JP2008253188A (ja) * 2007-04-04 2008-10-23 Tokyo Univ Of Science エンドサイトーシス依存性dna取り込み抑制剤、エンドサイトーシス依存性dna取り込み促進剤、ウイルス感染阻害剤、ウイルス感染予防剤、及びウイルス感染促進剤、並びに、遺伝子マーカー、モノクローナル抗体、ハイブリドーマ、及びそれらの使用方法。
US7734161B2 (en) * 2007-04-19 2010-06-08 Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. Image stabilization with adaptive shutter control
US9360489B2 (en) 2007-06-11 2016-06-07 Sutter Bay Hospitals Method and kit for dynamic gene expression monitoring
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
CN104267011A (zh) * 2014-09-23 2015-01-07 中国科学院东北地理与农业生态研究所 一种转基因羊卵母细胞的筛选方法
ES2799515T3 (es) 2015-05-22 2020-12-18 Dmitry Dmitrievich Genkin ADN extracelular como una diana terapéutica en la neurodegeneración
CN107677823A (zh) * 2016-08-02 2018-02-09 北京金沐医疗科技有限公司 一种用于检测肿瘤抗原的蛋白芯片试剂盒及其检测方法
CN107677822A (zh) * 2016-08-02 2018-02-09 北京金沐医疗科技有限公司 检测肿瘤标志物的荧光细胞计数检测试剂盒
CN107677820A (zh) * 2016-08-02 2018-02-09 北京金沐医疗科技有限公司 一种检测肿瘤抗原的试剂盒及其检测方法
AU2019209770B2 (en) 2018-01-16 2025-07-31 Cls Therapeutics Limited Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity
CN109406771B (zh) * 2018-10-26 2023-04-07 安徽大千生物工程有限公司 胱抑素c胶乳增强比浊法检测试剂盒及其制备使用方法
WO2020223265A1 (en) * 2019-04-28 2020-11-05 Essenlix Corporation Rapid pathology/cytology without wash
CN113314220B (zh) * 2021-07-28 2021-11-02 江苏为真生物医药技术股份有限公司 疾病病程监控系统、计算机可读存储介质以及电子设备

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19521046C1 (de) * 1995-06-09 1996-08-08 Deutsches Krebsforsch Protein mit DNase-Aktivität
WO2000052204A2 (en) * 1999-02-22 2000-09-08 Orntoft Torben F Gene expression in bladder tumors
US20020052308A1 (en) * 1999-03-12 2002-05-02 Rosen Craig A. Nucleic acids, proteins and antibodies
EP1249495A1 (de) * 2001-04-11 2002-10-16 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Murine DNase X, diese enthaltendes Arzneimittel und nicht-menschliches Säugetier mit verändertem DNase X-Gen
MXPA04004378A (es) * 2001-11-07 2004-09-10 Univ Arkansas Diagnostico, prognosis e identificacion de objetivos terapeuticos potenciales de mieloma multiple basado en el perfilado de expresion de genes.
CA2499709A1 (en) * 2002-06-19 2003-12-31 Yoichi Furukawa Method for diagnosis of colorectal tumors
DE60219809T2 (de) * 2002-12-18 2008-01-17 Coy, Johannes F., Dr. Verbindungen und Verfahren zur Nachweiss von Karzinomen und deren Vorstufen

Similar Documents

Publication Publication Date Title
JP6526870B2 (ja) 乳がんの検出を補助する方法、ポリペプチドプローブセット、およびポリヌクレオチドアレイ
JP2006510363A5 (https=)
JP4896994B2 (ja) Bcl−2レベルの上昇による癌の検出
CN1922490B (zh) 使用蛋白质组学技术鉴定癌症蛋白生物标志物的方法
Hai et al. Whole‐genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer
EP3353554A1 (en) Biomarkers for detection of breast cancer in women with dense breasts
CN106795557A (zh) 用于肺癌诊断的方法和系统
WO2016195051A1 (ja) 膵がんを診断するための血漿バイオマーカーパネル
TW202242130A (zh) 循環轉錄因子分析
US20240318255A1 (en) Transcription factor binding site analysis of nucleosome depleted circulating cell free chromatin fragments
JP2005523727A (ja) 腫瘍のバイオマーカーを発見して腫瘍を診断する方法
CN113355415B (zh) 用于食管癌诊断或辅助诊断的检测试剂及试剂盒
Dermawan et al. Novel PAX3:: MAML3 fusion identified in alveolar rhabdomyosarcoma, using DNA methylation profiling to expand the genetic spectrum of “fusion-positive” cases
TW201905207A (zh) 用於檢測肝癌的基因標誌物及其用途
KR20090063924A (ko) 대장암 과발현 유전자를 이용한 대장암 진단 마커
CN110438232A (zh) 一种肺腺癌诊断组合物及其应用
JP2008547006A5 (https=)
US20230133776A1 (en) Methods for diagnosing cancer
AU2021203920A1 (en) Biomarkers for detection of breast cancer
CN113215255B (zh) 用于肝癌早期诊断或预后的生物标记物及其用途
EP3963331B1 (en) Method for the detection of cancer
CN113846165A (zh) 生物标志物在预测结直肠癌对奥沙利铂治疗敏感性中的应用
EP4133108B1 (en) Eplin as a biomarker for cancer
US20260028678A1 (en) Assessment of biological samples for nucleic acid analysis
El-Naggar Lineage and Molecular Marker Integration in Diagnosis and Differential Diagnosis of Neck Tumors